| FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine | COVID-19 vaccine reactions: The difference between common and allergic reactions |
|---|---|
| Interim public health recommendations for vaccinated people | Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U |
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States.
8| Morbidity and Mortality Weekly Report | Centers for Disease Control and Prevention |
|---|---|
| Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers | Centers for Disease Control and Prevention |
Centers for Disease Control and Prevention.